.RESEARCH FEATURE.06 August 2024.
A large randomized regulated test along with cisgender women highlights the problems of obedience to an everyday oral preexposure treatment regiment and illustrates that twice-yearly shot of lenacapavir may maintain successful HIV prevention degrees over 6 months.